{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:51:46Z","timestamp":1791193906269,"version":"4.1.0"},"reference-count":38,"publisher":"Akademiai Kiado Zrt.","issue":"40","content-domain":{"domain":["www.akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2026,10,4]]},"abstract":"Sz\u00e1mos klinikai vizsg\u00e1lat \u00e9s k\u00eds\u00e9rletes eredm\u00e9ny igazolta, hogy a k\u00fcl\u00f6nb\u00f6z\u0151\n textur\u00e1lts\u00e1g\u00fa \u00e9s t\u00f6ltet\u0171 eml\u0151implant\u00e1tumok el\u0151seg\u00edthetik az implant\u00e1tum\n capsul\u00e1j\u00e1n bel\u00fcl a sejtek \u00e9s sz\u00f6vetek szerkezeti v\u00e1ltoz\u00e1s\u00e1t, ami hossz\u00fa t\u00e1von\n tumorgenezist induk\u00e1lhat. Az eml\u0151implant\u00e1tummal \u00f6sszef\u00fcgg\u0151 anaplasticus\n nagysejtes lymphoma (BIA-ALCL) \u00e9s a laph\u00e1mr\u00e1k (BIA-SCC) k\u00e9t k\u00fcl\u00f6n\u00e1ll\u00f3, az\n eml\u0151daganatt\u00f3l \u00e9lesen elk\u00fcl\u00f6n\u00fcl\u0151, az implant\u00e1tum capsul\u00e1j\u00e1ban kialakul\u00f3 malignus\n megbeteged\u00e9s, amelyek becs\u00fclt el\u0151fordul\u00e1si gyakoris\u00e1ga \u00e9s prevalenci\u00e1ja\n alacsony. A WHO \u00e1ltal 2023 \u00f3ta elismert eml\u0151implant\u00e1tum-laph\u00e1mr\u00e1k immunol\u00f3giai\n term\u00e9szet\u0171, kr\u00f3nikus antig\u00e9nstimul\u00e1ci\u00f3val \u00f6sszef\u00fcgg\u0151 gyullad\u00e1sos folyamat\n k\u00f6vetkezm\u00e9nye, amelyn\u00e9l a daganatok kialakul\u00e1s\u00e1nak t\u00e9nyleges kock\u00e1zata \u00e9s\n kiv\u00e1lt\u00f3 t\u00e9nyez\u0151i m\u00e9g nem tiszt\u00e1zottak, de a tumorokkal \u00f6sszef\u00fcgg\u0151 genetikai\n mut\u00e1ci\u00f3k \u00e9s k\u00f6rnyezeti hat\u00e1sok vizsg\u00e1lata tov\u00e1bbra is a tudom\u00e1nyos \u00e9rdekl\u0151d\u00e9s\n k\u00f6z\u00e9ppontj\u00e1ban \u00e1ll. A CK5\/6- \u00e9s p40\/p63 pozitivit\u00e1sok melletti immunhi\u00e1nyos\n \u00e1llapot sziszt\u00e9m\u00e1s t\u00fcnetei (l\u00e1z, kr\u00f3nikus f\u00e1radts\u00e1g, gyenges\u00e9g) kev\u00e9sb\u00e9\n prominensek. A lok\u00e1lis t\u00fcnetek (k\u00e9s\u0151i seroma, az eml\u0151 f\u00e1jdalmas duzzanata,\n aszimmetria, tokmegvastagod\u00e1s, b\u0151rt\u00fcnetek) domin\u00e1lnak, \u00e9s \u00e1tlagosan 15\u201320 \u00e9vvel\n az implant\u00e1ci\u00f3 ut\u00e1n jelentkeznek. A k\u00e9palkot\u00f3 vizsg\u00e1latok (ultrahang, MRI,\n finomt\u0171-biopszia, CT, PET\/CT) ut\u00e1ni pozit\u00edv citol\u00f3giai \u00e9s immunhisztok\u00e9mia\n vizsg\u00e1lati eredm\u00e9nyek lokaliz\u00e1lt esetekben j\u00f3 progn\u00f3zist mutatnak. Az\n eml\u0151implant\u00e1tum-laph\u00e1mr\u00e1kkal diagnosztiz\u00e1lt betegek 80%-\u00e1n\u00e1l a diagn\u00f3zis\n fel\u00e1ll\u00edt\u00e1sakor m\u00e1r capsul\u00e1n k\u00edv\u00fcli tumoros inv\u00e1zi\u00f3 mutathat\u00f3 ki a h\u00f3nalj, a\n v\u00e9gtagok, a m\u00e1j, a t\u00fcd\u0151, az izmok, a csontok, a ves\u00e9k \u00e9s az agyh\u00e1rtya ter\u00fclet\u00e9n.\n Az eml\u0151implant\u00e1tum-laph\u00e1mr\u00e1k invazivit\u00e1s\u00e1t mutatja, hogy a regisztr\u00e1lt esetekn\u00e9l\n a 6 h\u00f3napos mortalit\u00e1si ar\u00e1ny nagyon nagy: 43,8% volt. Az ell\u00e1t\u00e1snak\n multidiszciplin\u00e1ris szakmai r\u00e9szv\u00e9tellel kell t\u00f6rt\u00e9nnie, \u00e9s az eseteket\n haz\u00e1nkban a Nemzeti Eg\u00e9szs\u00e9gbiztos\u00edt\u00e1si Alapkezel\u0151 K\u00f6zponti\n Implant\u00e1tumregiszter\u00e9ben k\u00f6telez\u0151en jelenteni kell. A plasztikai seb\u00e9szeti \u00e9s\n onkol\u00f3giai kutat\u00e1sokon t\u00fal minden orvosnak tiszt\u00e1ban kell lennie azzal, hogy\n fontos figyelni az eml\u0151implant\u00e1tummal rendelkez\u0151 betegek jelz\u00e9seit \u00e9s t\u00fcneteit,\n illetve klinikai gyan\u00fa eset\u00e9n megfelel\u0151 diagnosztikai vizsg\u00e1latok fel\u00e9 kell\n ir\u00e1ny\u00edtani a p\u00e1cienseket. A jelen tanulm\u00e1ny az eml\u0151implant\u00e1tum-laph\u00e1mr\u00e1k\n epidemiol\u00f3giai t\u00e9nyez\u0151it, a patogenezisre, a genetikai \u00e9s klinikai szempontokra,\n a kezel\u00e9sre \u00e9s a progn\u00f3zisra vonatkoz\u00f3 ismereteinket foglalja \u00f6ssze. Orv Hetil.\n 2026; 167(40): 1585\u20131592.<\/jats:p>","DOI":"10.1556\/650.2026.33682","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:58:52Z","timestamp":1791190732000},"page":"1585-1592","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":0,"title":["Az eml\u0151implant\u00e1tummal \u00f6sszef\u00fcgg\u0151 laph\u00e1mr\u00e1k"],"prefix":"10.1556","volume":"167","author":[{"given":"Andrea","family":"Ferencz","sequence":"first","affiliation":[{"name":"Budapesti P\u00e9terfy S\u00e1ndor Utcai K\u00f3rh\u00e1z-Rendel\u0151int\u00e9zet, Seb\u00e9szeti Oszt\u00e1ly Budapest Magyarorsz\u00e1g"},{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Doktori Iskola Budapest Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8564-2726","authenticated-orcid":true,"given":"B\u00e9la Zolt\u00e1n","family":"Debreczeni","sequence":"additional","affiliation":[{"name":"DrD Plasztikai St\u00fadi\u00f3 Budapest, Kuny Domokos \u00fat 1., 1012 Magyarorsz\u00e1g"},{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Doktori Iskola Budapest Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"D\u2019Orsi G, Giacalone M, Calicchia A, et al. BIA-ALCL and BIA-SCC:\n updates on clinical features and genetic mutations for latest recommendations.\n Medicina (Kaunas) 2024; 60: 793.\n https:\/\/doi.org\/10.3390\/medicina60050793","DOI":"10.3390\/medicina60050793"},{"key":"R2","unstructured":"U.S. Food and Drug Administration. Breast implants: reports of\n squamous cell carcinoma and various lymphomas in capsule around implants: FDA\n safety communication. Available from:\n https:\/\/www.fda.gov\/medical-devices\/safety-communications\/breastimplants-reports-squamous-cell-carcinoma-and-various-lymphomas-capsule-around-implants-fda\n [accessed: 23 March 2024]."},{"key":"R3","doi-asserted-by":"crossref","unstructured":"De Oliveira-Junior I, Gonzaga MI, Amirati CC, et al. Primary breast\n implant-associated squamous cell carcinoma: a proposal for a better surgical\n approach and clinical staging system based on tumour characteristics. Ann Surg\n Oncol. 2025; 32: 9857-9867.\n https:\/\/doi.org\/10.1245\/s10434-025-17873-x","DOI":"10.1245\/s10434-025-17873-x"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Glasberg SB, Sommers CA, McClure GT. Breast implant-associated\n squamous cell carcinoma: initial review and early recommendations. Plast\n Reconstr Surg Glob Open 2023; 11: e5072.\n https:\/\/doi.org\/10.1097\/GOX.0000000000005072","DOI":"10.1097\/GOX.0000000000005072"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Kitchen SB, Paletta CE, Shehadi SI, et. al. Epithelialization of the\n lining of a breast implant capsule. Possible origins of squamous cell carcinoma\n associated with a breast implant capsule. Cancer 1994; 73: 1449-1452.\n https:\/\/doi.org\/10.1002\/1097-0142(19940301)73:5<1449::AID-CNCR2820730520>3.0.CO2-J;","DOI":"10.1002\/1097-0142(19940301)73:5<1449::AID-CNCR2820730520>3.0.CO;2-J"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Brand KG, Buoen LC, Johnson KH, et al. Etiological factors, stages,\n and the role of the foreign body in body tumorigenesis a review. Cancer Res.\n 1975; 35: 279-286.\n https:\/\/doi.org\/10.1097\/00006534-197507000-00064","DOI":"10.1097\/00006534-197507000-00064"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Buchanan PJ, Chopra VK, Walker KL, et al. Primary squamous cell\n carcinoma arising from a breast implant capsule: a case report and review of the\n literature. Aesthet Surg J. 2018; 38: NP97-NP102.\n https:\/\/doi.org\/10.1093\/asj\/sjy092","DOI":"10.1093\/asj\/sjy092"},{"key":"R8","unstructured":"Ferencz A, Nagy I, Bl\u00e1zovics A, et al. Oxido-reductive aspects of\n human breast tumors. In: Hagym\u00e1si K, Janda T, Po\u00f3r P. (eds.) Advances in\n reactive oxygen species and antioxidant defense. [A hum\u00e1n eml\u0151tumorok\n oxido-redukt\u00edv vonatkoz\u00e1sai. In: Hagym\u00e1si K, Janda T, Po\u00f3r P. (szerk.) A reakt\u00edv\n oxig\u00e9nform\u00e1kkal \u00e9s az antioxid\u00e1ns v\u00e9dekez\u00e9ssel kapcsolatos \u00fajdons\u00e1gok.] Magyar\n Szabadgy\u00f6k-Kutat\u00f3 T\u00e1rsas\u00e1g, Budapest, 2024; pp. 119-128.\n [Hungarian]"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Nagy I, Kisa-Nagy V, Bozs\u00f3 Sz, et al. Effects of antioxidant and\n anti-inflammatory topical treatments on the phases of wound healing and their\n comparative analysis. [A sebgy\u00f3gyul\u00e1si f\u00e1zisok folyamatait befoly\u00e1sol\u00f3\n antioxid\u00e1ns \u00e9s antiinflammatorikus topik\u00e1lis kezel\u00e9sek hat\u00e1sai \u00e9s \u00f6sszehasonl\u00edt\u00f3\n elemz\u00e9s\u00fck.] Orv Hetil. 2026; 167: 109-118. [Hungarian]\n https:\/\/doi.org\/10.1556\/650.2026.33460","DOI":"10.1556\/650.2026.33460"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Ferencz A. Diagnosis and monitoring of malignant diseases with\n thermoanalytical measurement of one drop blood. [Malignus betegs\u00e9gek\n diagnosztik\u00e1ja \u00e9s ut\u00e1nk\u00f6vet\u00e9se egy csepp v\u00e9r termoanalitikai vizsg\u00e1lat\u00e1val.] Orv\n Hetil. 2026; 167: 98-108. [Hungarian]\n https:\/\/doi.org\/10.1556\/650.2026.33462","DOI":"10.1556\/650.2026.33462"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Nagy I, Kisa-Nagy V, Bozs\u00f3 Sz, et al. Paradigm shifts in hydrogen\n peroxide from surgery to cellular signaling. [A hidrog\u00e9n-peroxid\n paradigmav\u00e1lt\u00e1sai a seb\u00e9szett\u0151l a cellul\u00e1ris jel\u00e1tvitelig.] Orv Hetil. 2026;\n 167: 119-128. [Hungarian]\n https:\/\/doi.org\/10.1556\/650.2026.33461","DOI":"10.1556\/650.2026.33461"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"DeCoster RC, Clemens MW, Di Napoli AM, et al. Cellular and molecular\n mechanisms of breast implant-associated anaplastic large cell lymphoma. Plast\n Reconstr Surg. 2021; 147: 30e-41e.\n https:\/\/doi.org\/10.1097\/PRS.0000000000007423","DOI":"10.1097\/PRS.0000000000007423"},{"key":"R13","unstructured":"Zapf I, Fekecs T, Moezzi M, et al. Differential scanning calorimetry\n (DSC) data of blood plasma in breast cancer patients. [Eml\u0151daganatos betegek\n v\u00e9rplazm\u00e1j\u00e1nak differenci\u00e1l p\u00e1szt\u00e1z\u00f3 kalorimetri\u00e1s vizsg\u00e1lata.] Magy Onk. 2012;\n 56: 274-279. [Hungarian]"},{"key":"R14","unstructured":"Philip J. Squamous cell carcinoma arising at the site of an\n under-lying bullet. J Coll Surg Edinb. 1982; 27: 365-366."},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Smahel J, Clodius L. Epidermal lining in the capsule of a breast\n prosthesis. Br J Plast Surg. 1978; 31: 173-175.\n https:\/\/doi.org\/10.1016\/0007-1226(78)90073-5","DOI":"10.1016\/0007-1226(78)90073-5"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Pagliara D, Grieco F, Cuomo R, et al. Breast implant-associated\n squamous cell carcinoma: an evidence-based systematic review. Eur J Plast Surg.\n 2023; 46: 875-886.\n https:\/\/doi.org\/10.1007\/s00238-023-02078-w","DOI":"10.1007\/s00238-023-02078-w"},{"key":"R17","unstructured":"American Society of Plastic Surgeons. FDA provides update on breast\n implant associated-squamous cell carcinoma (BIA-SCC) Available from:\n https:\/\/associationofbreastsurgery.org.uk\/media\/pc2cmplc\/may-fda-provides-update-on-breast-implant-associated.pdf\n [accessed: March 8, 2023]."},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Jagasia PM, DeYoung J, Franco MP, et al. Squamous expression in\n breast implant capsules: insights into the pathogenesis of breast\n implant-associated scuamous cell carcinoma. Plastic Reconst Surg. 2026 Mar 27.\n https:\/\/doi.org\/10.1097\/PRS.0000000000013079\n https:\/\/doi.org\/10.1097\/PRS.0000000000013079","DOI":"10.1097\/PRS.0000000000013079"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Fracol ME, Miranda RN, Tsao AS, et al. Breast implant-associated\n malignancies: Current recommendations for workup and management. Plast Reconstr\n Surg. 2026; 157: 774e-784e.\n https:\/\/doi.org\/10.1097\/PRS.0000000000012796","DOI":"10.1097\/PRS.0000000000012796"},{"key":"R20","unstructured":"American Society of Plastic Surgeons. ASPS statement on breast\n implant associated squamous cell carcinoma (BIA-SCC). 2022. Available from:\n https:\/\/www.plasticsurgery.org\/for-medical-professionals\/publications\/psn-extra\/news\/asps-statement-on-breast-implant-associated-squamous-cell-carcinoma\n [accessed: 23 March 2024]."},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Camicia A, Foppiani JA, Raska O, et al. From case reports to\n molecular insight: examining the outcomes and underlying mechanisms of squamous\n cell carcinoma in breast implant patients - a systematic review. Int J Mol Sci.\n 2024; 25: 2872. https:\/\/doi.org\/10.3390\/ijms25052872","DOI":"10.3390\/ijms25052872"},{"key":"R22","unstructured":"National Health Insurance Fund Administration. Implant Register.\n [Nemzeti Eg\u00e9szs\u00e9gbiztos\u00edt\u00e1si Alapkezel\u0151. Implant\u00e1tumregiszter.] Available from:\n https:\/\/impreg.neak.gov.hu [accessed: 23 March 2024].\n [Hungarian]"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Zhou YM, Chaudhry HE, Shah A, et al. Breast squamous cell carcinoma\n following breast eugmentation. Cureus 2018; 10: e3405.\n https:\/\/doi.org\/10.7759\/cureus.3405","DOI":"10.7759\/cureus.3405"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Zomerlei TA, Samarghandi A, Terando AM. Primary squamous cell\n carcinoma arising from a breast implant capsule. Plast Reconstr Surg Glob Open\n 2016; 3: e586.\n https:\/\/doi.org\/10.1097\/GOX.0000000000000567","DOI":"10.1097\/GOX.0000000000000567"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Ferencz A, Zapf I, L\u0151rinczy D. Harmful effect of neoadjuvant\n chemotherapy monitoring by DSC on breast cancer patients\u2019 blood plasma. J Therm\n Anal Calorim. 2016; 126: 55-59.\n https:\/\/doi.org\/10.1007\/s10973-016-5291-3","DOI":"10.1007\/s10973-016-5291-3"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Ferencz A, Szatm\u00e1ri D, L\u0151rinczy D. Thermodynamic sensitivity of\n blood plasma components in patients afflicted with skin, breast and pancreatic\n forms of cancer. Cancers 2022; 14: 6147.\n https:\/\/doi.org\/10.3390\/cancers14246147","DOI":"10.3390\/cancers14246147"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Di Pompeo S, Firmani F, Stanzani G, et al. Breast implants and the\n risk of squamous cell carcinoma of the breast: a systematic literature review\n and epidemiologic study. Aesthet Surg J. 2024; 44: 757-768.\n https:\/\/doi.org\/10.1093\/asj\/sjae023","DOI":"10.1093\/asj\/sjae023"},{"key":"R28","unstructured":"U.S. Food and Drug Administration. Update: Reports of squamous cell\n carcinoma (SCC) in the capsule around breast implants - FDA safety\n communication. Available from:\n https:\/\/www.fda.gov\/medical-devices\/safety-communications\/update-reports-squamous-cell-carcinoma-scc-capsule-around-breast-implants-fda-safety-communication\n [accessed: 23 March 2024]."},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Rogges E, Petrino MM, Firmani G, et al. Metaplastic carcinoma of the\n breast mimicking breast implant-associated squamous cell carcinoma: a\n challenging differential diagnosis. Case Rep Plast Surg Hand Surg. 2025; 12:\n 2486239.\n https:\/\/doi.org\/10.1080\/23320885.2025.2486239","DOI":"10.1080\/23320885.2025.2486239"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Mazzocchi M, Dessy LA, Corrias F, et al. A clinical study of late\n seroma in breast implantation surgery. Aesthetic Plast Surg. 2012; 36: 97-104.\n https:\/\/doi.org\/10.1007\/s00266-011-9755-3","DOI":"10.1007\/s00266-011-9755-3"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"Niraula S, Katel A, Barua A, et al. A systematic review of breast\n implant-associated squamous cell carcinoma. Cancers (Basel) 2023; 15: 4516.\n https:\/\/doi.org\/10.3390\/cancers15184516","DOI":"10.3390\/cancers15184516"},{"key":"R32","doi-asserted-by":"crossref","unstructured":"Olsen DL, Keeney GL, Chen B, et al. Breast implant\n capsule-associated squamous cell carcinoma: a report of 2 cases. Hum Pathol.\n 2017; 67: 94-100.\n https:\/\/doi.org\/10.1016\/j.humpath.2017.07.011","DOI":"10.1016\/j.humpath.2017.07.011"},{"key":"R33","doi-asserted-by":"crossref","unstructured":"Goldberg MT, Llaneras J, Willson TD, et al. Squamous cell carcinoma\n arising in breast implant capsules. Ann Plast Surg. 2021; 86: 268-272.\n https:\/\/doi.org\/10.1097\/SAP.0000000000002524","DOI":"10.1097\/SAP.0000000000002524"},{"key":"R34","doi-asserted-by":"crossref","unstructured":"Xia Z, Han B, Wang L, et al. Breast implant-associated squamous cell\n carcinoma in a male patient. A case report and review of the medical literature.\n Front Surg. 2023; 9: 983611.\n https:\/\/doi.org\/10.3389\/fsurg.2022.983611","DOI":"10.3389\/fsurg.2022.983611"},{"key":"R35","doi-asserted-by":"crossref","unstructured":"Soni SE, Laun JC, Beard AS, et al. Breast implant capsule-associated\n squamous cell carcinoma during pregnancy: a mimicker of breast\n implant-associated anaplastic large-cell lymphoma. Plast Reconstr Surg. 2022;\n 150: 926e-928e.\n https:\/\/doi.org\/10.1097\/PRS.0000000000009506","DOI":"10.1097\/PRS.0000000000009506"},{"key":"R36","doi-asserted-by":"crossref","unstructured":"Clemens MW, Fracol ME, Rodriguez MN, et al. EP14.03-05 Implant\n associated squamous cell carcinoma: an emerging chest wall malignancy. J Thorac\n Oncol. 2023; 18: S722-S723.\n https:\/\/doi.org\/10.1016\/j.jtho.2023.09.1396","DOI":"10.1016\/j.jtho.2023.09.1396"},{"key":"R37","doi-asserted-by":"crossref","unstructured":"Fracol ME, Rodriguez MM, Clemens MW. A spectrum of disease: breast\n implant-associated anaplastic large cell lymphoma, atypicals, and other implant\n associations. Clin Plast Surg. 2023; 50: 249-257.\n https:\/\/doi.org\/10.1016\/j.cps.2022.12.001","DOI":"10.1016\/j.cps.2022.12.001"},{"key":"R38","unstructured":"Debreczeni BZ. Management of patient-complaints in the plastic\n surgery. [Betegpanaszok kezel\u00e9se a plasztikai seb\u00e9szet ter\u00fclet\u00e9n.] Med &\n Jur. 2025; 16: 4-13. [Hungarian]"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/www.akjournals.com\/view\/journals\/650\/167\/40\/article-p1585.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.akjournals.com\/downloadpdf\/journals\/650\/167\/40\/article-p1585.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.akjournals.com\/downloadpdf\/journals\/650\/167\/40\/article-p1585.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:59:01Z","timestamp":1791190741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.akjournals.com\/view\/journals\/650\/167\/40\/article-p1585.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,4]]},"references-count":38,"journal-issue":{"issue":"40"},"URL":"https:\/\/doi.org\/10.1556\/650.2026.33682","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,4]]}}}